![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Sun Pharmaceutical Industries (australia) Pty Ltd. Port Fairy Au, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their significant offerings is Codeine phosphate hemihydrate, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-100 - Rev 04
This Chemical Type CEP, issued on December 03, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 74 associated with this CEP further emphasizes